Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||
| Net Income | -72,282 | -29,955 | -27,190 |
| Depreciation Amortization | 678 | N/A | N/A |
| Accounts receivable | -612 | N/A | N/A |
| Accounts payable and accrued liabilities | -482 | 1,106 | 157 |
| Other Working Capital | 5,413 | 1,942 | 7,563 |
| Other Operating Activity | 13,619 | 16,008 | 18,483 |
| Operating Cash Flow | $-53,666 | $-10,899 | $-987 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -367 | -62 | N/A |
| Purchase Sale Intangibles | N/A | -1,000 | N/A |
| Other Investing Activity | 0 | -1,000 | 0 |
| Investing Cash Flow | $-367 | $-1,062 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 20,000 | N/A | N/A |
| Common Stock Issued | 80,139 | 86,413 | N/A |
| Other Financing Activity | -36,386 | -8,315 | 29,696 |
| Financing Cash Flow | $63,753 | $78,098 | $29,696 |
| Beginning Cash Position | 94,846 | 28,709 | N/A |
| End Cash Position | 104,566 | 94,846 | 28,709 |
| Net Cash Flow | $9,720 | $66,137 | $28,709 |
| Free Cash Flow | |||
| Operating Cash Flow | -53,666 | -10,899 | -987 |
| Capital Expenditure | -367 | -62 | N/A |
| Free Cash Flow | -54,033 | -10,961 | -987 |